Department of Neurosurgery, Lariboisiere University Hospital, Paris, France.
Neurosurg Rev. 2012 Jul;35(3):331-38; discussion 338-40. doi: 10.1007/s10143-011-0370-1. Epub 2012 Jan 19.
The endoscopic approach has gained an increased popularity in recent years for the biopsy and, in selected cases, the removal of tumors of the posterior third ventricle and pineal region. The authors report their experience on a series of 20 patients discussing also the technical limitations and complication avoidance. This is a prospective study of 20 patients with posterior third ventricle and pineal region tumors surgically managed by endoscopic biopsy and/or excision and simultaneous third ventriculostomy. The removal of the lesion could be achieved in 12 cases whereas in 8, only a biopsy could be performed. A histological diagnosis could be obtained in all cases. No delayed third ventricular stoma failures were recorded in any patient at the latest follow-up (mean follow-up, 39 months). Severe postoperative complications were recorded in 2 out of 12 cases of tumor removal attempt and in zero out of eight cases of biopsy. A delayed (3 weeks) postoperative mortality occurred in a patient harboring a GBM that developed an intratumoral hematoma 48 h postoperatively, one patient was in a vegetative state. Transient postoperative complications included: nausea and vomiting (five cases) and diplopia (two cases). One patient developed a bilateral ophthalmoplegia that recovered within 6 months due to residual tumor hemorrhage. Higher rate of complications was found in the case of vascularized and/or larger lesions. Endoscopic management of posterior third ventricle lesions may represent an effective option. However, though biopsies remain often a safe procedure, tumor excision should be limited to highly selected cases (cystic, poorly vascularized, and/or smaller than 2.5-cm lesions).
内镜方法近年来在活检中越来越受欢迎,在某些情况下,还可用于切除第三脑室后部和松果体区域的肿瘤。作者报告了他们对 20 例患者的一系列经验,还讨论了技术限制和并发症预防。这是一项对 20 例第三脑室后部和松果体区域肿瘤患者进行内镜活检和/或切除及同期第三脑室造口术的前瞻性研究。在 12 例患者中,可通过切除来清除病变,而在 8 例患者中,仅能进行活检。所有患者均获得了组织学诊断。在最新随访时(平均随访时间为 39 个月),未记录到任何患者的第三脑室造口术延迟失败。在 12 例尝试切除肿瘤的病例中有 2 例和 8 例活检病例中无 0 例出现严重术后并发症。在一名患有 GBM 的患者中,术后 3 周发生迟发性死亡,该患者在术后 48 小时发生肿瘤内血肿。1 名患者处于植物人状态。术后一过性并发症包括:恶心和呕吐(5 例)和复视(2 例)。1 例患者发生双侧动眼神经麻痹,由于残余肿瘤出血,在 6 个月内恢复。血管丰富和/或较大的病变发生并发症的风险更高。内镜治疗第三脑室后部病变可能是一种有效的选择。然而,虽然活检仍然是一种安全的操作,但肿瘤切除应仅限于高度选择的病例(囊性、血供差和/或小于 2.5 厘米的病变)。